| Literature DB >> 31698783 |
Lucia Ya Zakharova1,2, Tatiana N Pashirova1, Slavomira Doktorovova3, Ana R Fernandes3, Elena Sanchez-Lopez3,4,5,6, Amélia M Silva7,8, Selma B Souto9, Eliana B Souto3,10.
Abstract
The development of biotechnological protocols based on cationic surfactants is a modern trend focusing on the fabrication of antimicrobial and bioimaging agents, supramolecular catalysts, stabilizers of nanoparticles, and especially drug and gene nanocarriers. The main emphasis given to the design of novel ecologically friendly and biocompatible cationic surfactants makes it possible to avoid the drawbacks of nanoformulations preventing their entry to clinical trials. To solve the problem of toxicity various ways are proposed, including the use of mixed composition with nontoxic nonionic surfactants and/or hydrotropic agents, design of amphiphilic compounds bearing natural or cleavable fragments. Essential advantages of cationic surfactants are the structural diversity of their head groups allowing of chemical modification and introduction of desirable moiety to answer the green chemistry criteria. The latter can be exemplified by the design of novel families of ecological friendly cleavable surfactants, with improved biodegradability, amphiphiles with natural fragments, and geminis with low aggregation threshold. Importantly, the development of amphiphilic nanocarriers for drug delivery allows understanding the correlation between the chemical structure of surfactants, their aggregation behavior, and their functional activity. This review focuses on several aspects related to the synthesis of innovative cationic surfactants and their broad biological applications including antimicrobial activity, solubilization of hydrophobic drugs, complexation with DNA, and catalytic effect toward important biochemical reaction.Entities:
Keywords: 1,4-diazabicyclo[2.2.2]octane; antimicrobial nanocarriers; cationic surfactants; drug delivery systems; self-assembly; solubilization
Mesh:
Substances:
Year: 2019 PMID: 31698783 PMCID: PMC6888607 DOI: 10.3390/ijms20225534
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Examples of cationic quaternary ammonium surfactants, 1a: R = CnHn+1, s = 4; 1b: R = CnHn+1, n = 2,4; 1c: R = C12H25, C16H37, C18H37, n = 3; 1d: n = 10; 1f: R = C10H21, X− = Br−; 1g: n = 10, 12, 14; and 1h: n = 6, 9, 12.
Examples of amino-acid residue containing quaternary ammonium compounds (QACs).
| Amino Acid | Type of QAS | Type of Aggregates | References |
|---|---|---|---|
| Alanine | Gemini ester quat surfactants | / | [ |
| Arginine | Alkylated Arg (LAM), gemini alkylated Arg (C6(LA2); C9(LA2), C12(LA2)) | LAM, C6(LA2) -Micelles, C9(LA2), C12(LA2)-vesicles | [ |
| Diacylglycero Arg | Vesicles | [ | |
| Lysine | / | Lysine-surfactants in liposomes | [ |
| Lysine-gel based systems | [ | ||
| Serine | / | Serine-gene delivery systems | [ |
Figure 2Structural formulas of quaternized derivatives of quinuclidine (1a–d) and monocationic (1,4-diazobicyclo[2.2.2]octane (DABCO)-n) (3a–d), dicationic (Et-DABCO-n) (4-Et a–d), (C2H4OH-DABCO-n) (4-C2H4OH a–d), (4-C2H4OC6H5 a–d), and tetracationic gemini n-DABCO-2-Dabco-n (5a–d) surfactants.
Values of CMC of cationic surfactants in water.
| Surfactant | Additives | CMC × 103 (M) (Based on Different Techniques) | Refs | |||||
|---|---|---|---|---|---|---|---|---|
| Tensiometry | Conductometry | Potentiometry | NMR | Fluorimetry | Spectrophotometry | |||
| 2b | 2.5 | 2.85 | 3.0 | 1.5 | ||||
| 2c | 0.85 | 0.6 | 0.94 | 0.8 | ||||
| 2d | 0.2 | 0.24 | 0.3 | 0.3 | ||||
| 3a | 11 | 14 | 16 | 15 | - | [ | ||
| 3b | 4.0 | 3.0 | 3.7 | 3.4 | 4.3 | [ | ||
| 3c | 1.0 | 1.0 | 1.9 | 0.85 | [ | |||
| 3d | 0.24 | 0.11 | 0.22 | 0.11 | - | [ | ||
| 4a-Et | 26.5 | 28.4 | 29.7 | 28 | [ | |||
| 4b-Et | 10.3 | 8.5 | 8.4 | 8.1 | 9.5 | [ | ||
| 4c-Et | 3.0 | 3.1 | 2.0 | - | - | 2.3 | [ | |
| 4c-EtOH | 2.0 | 2.5 | 3.0 | - | - | - | [ | |
| 4d-Et | 0.80 | 0.83 | 0.98 | 1.1 | [ | |||
| 5b | 4.0 | 3.0 | 2.0 | 4.2 | 3.6 | [ | ||
| 5c | 1.5 | 1.7 | 2.3 | 0.8 | 1.7 | [ | ||
| 5d | 0.5 | 0.5 | 0.15 | 0.29 | 0.2 | [ | ||
| 3c | CR-1 | 2 | 0.1 | - | - | - | - | [ |
| 4c-Et | CR-1 | 1.5 | 1.5 | - | - | - | 0.8 | [ |
| 5c | CR-1 | 1 | 0.4 | - | - | - | - | [ |
| 3c | CR-1 | 0.4 | 0.1 | 4.9 | 0.45 | - | 5.0 | [ |
Figure 3The effect critical micelle concentration (CMC) on chain length (n) and amount of charge of cationic surfactants based on DABCO and quinuclidine, quinuclidine (Q-Nuc-n) (1), mono-DABCO-n (2), di-DABCO-Et-n (3), and tetra n-DABCO-s-DABCO-n (4) 25 °C.
Figure 4The solubilization capacity of micellar aggregates based on quaternized derivatives of DABCO and trimethyl ammonium (TMA) analogs toward the dye Orange OT.
Figure 5Changes in the supramolecular architecture with the variation in the calixresorcine ratio: The controllable guest release.
Figure 6Changes in the morphology with the variation in the surfactants-calixresorcine ratio.
Figure 7Scheme of alkaline hydrolysis of phosphorus acid esters.